Table 3. Results and Outcomes of each cohorts of 10,000 HIV infected pregnant women.
Status | Feeding patterns | Incremental cost US($) | Infant HIV cases averted | Life years saved | Incremental cost-effectiveness | ||
Total | Incremental cost (per, $) | Total | Incremental cost(per, $) | ||||
Baseline | - | - | - | - | - | - | - |
(no intervention) | |||||||
Promptly treated cohort | - | 2063.05 | 698 | 1439391.2 | 21009.8 | 68.51 | Undominated§ |
Remedy cohort | - | 3579.66 | 110 | 391806.75 | 3311 | 118.33 | Extended dominated& |
Untreated cohort | Breastfeed | - | - | - | - | - | - |
Untreated cohort | Replacement feed | 1461.19 | 1073 | 1568400 | 32297.3 | 48.56 | Undominated |
Promptly treated cohort | Replacement feed | 4059.88 | 883 | 3584863.5 | 26578.3 | 134.88 | Undominated |
Remedy cohort | Breastfeed | 1508.69 | 421 | 635167.86 | 12672.1 | 50.12 | Extended dominated |
Promptly treated cohort | Breastfeed | 5826.72 | 360 | 2094217.3 | 10836 | 193.26 | Extended dominated |
Remedy cohort | Replacement feed | 37296.63 | 11 | 383788.86 | 331.1 | 1159.13 | Extended dominated |
: extended dominated, means exclude any interventions that have a higher ICER than more effective interventions.
: undominated, strategies on the cost-effectiveness frontier, meaning that they are more cost-effective.